| RS2061653516 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2061654524 |
SCN5A
|
Health Risk |
Pathogenic |
Brugada syndrome, Brugada syndrome |
| RS2061658179 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2061658738 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2061661681 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2061661896 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2061687300 |
SCN5A
|
Health Risk |
Likely pathogenic |
Long QT syndrome 3, Brugada syndrome 1 |
| RS2061688760 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Cardiac arrhythmia |
| RS2061701575 |
PORCN
|
Health Risk |
Likely pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2061710859 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2061711476 |
PORCN
|
Health Risk |
Pathogenic |
— |
| RS2061711638 |
PORCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2061714949 |
PORCN
|
Health Risk |
Pathogenic |
Focal dermal hypoplasia, Focal dermal hypoplasia |
| RS2061721973 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS2061743269 |
ATP2B2
|
Health Risk |
Pathogenic |
— |
| RS2061745581 |
HUWE1
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked syndromic |
| RS2061755379 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2061758031 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2061767463 |
MLC1
|
Health Risk |
Likely pathogenic |
— |
| RS2061771803 |
EBP
|
Health Risk |
Pathogenic |
Chondrodysplasia punctata 2 X-linked dominant, Chondrodysplasia punctata 2 X-linked dominant |
| RS2061781897 |
EBP
|
Health Risk |
Likely pathogenic |
— |
| RS2061782205 |
EBP
|
Health Risk |
Pathogenic |
— |
| RS2061808524 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome, Hao-Fountain syndrome |
| RS2061840290 |
PRDM15
|
Health Risk |
Likely pathogenic |
Pervasive developmental disorder, Pervasive developmental disorder |
| RS2061841667 |
USP7
|
Health Risk |
Pathogenic |
Hao-Fountain syndrome due to USP7 mutation, Hao-Fountain syndrome due to USP7 mutation |
| RS2061843481 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS2061854079 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2061855838 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS2061856480 |
BRIP1
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS2061880735 |
TCF3
|
Health Risk |
Pathogenic |
Agammaglobulinemia 8, autosomal dominant |
| RS2061886135 |
TTBK2
|
Health Risk |
Pathogenic |
— |
| RS2061958215 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, 8 conditions |
| RS2061959730 |
FAN1
|
Health Risk |
Pathogenic |
— |
| RS2061972270 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2061993910 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062007860 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2062008042 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062008854 |
SCN5A
|
Health Risk |
Likely pathogenic |
Brugada syndrome 1, Brugada syndrome 1 |
| RS2062020547 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062022344 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062027006 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062043035 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062046121 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2062047006 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062048292 |
CTNND1
|
Health Risk |
Likely pathogenic |
Cleft lip with or without cleft palate, Blepharocheilodontic syndrome 2 |
| RS2062049610 |
CTNND1
|
Health Risk |
Pathogenic/Likely pathogenic |
Blepharocheilodontic syndrome 2, Blepharocheilodontic syndrome 2 |
| RS2062054043 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2062054591 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062057035 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062057713 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062057880 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062060149 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062064773 |
ADA2
|
Health Risk |
Pathogenic |
Sneddon syndrome, Sneddon syndrome |
| RS2062066871 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062067746 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062067810 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062069547 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062076867 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062077684 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062078281 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062079566 |
MLC1
|
Health Risk |
Pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062087795 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062087915 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062089336 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062089925 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062090760 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062095528 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062114611 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2062114648 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2062115605 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062115822 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062118353 |
TCF4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2062118599 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2062156506 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062158779 |
SCN5A
|
Health Risk |
Pathogenic |
— |
| RS2062169124 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062169220 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062169243 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2062169927 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS2062171554 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
FANCA-related disorder, Fanconi anemia |
| RS2062172011 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062172051 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062172394 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2062172440 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2062172458 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062186534 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS2062200939 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2062203038 |
ATP2B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2062209732 |
USP9X
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 99 |
| RS2062210802 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2062211067 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2062220124 |
COLQ
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome 5 |
| RS2062239718 |
MLC1
|
Health Risk |
Pathogenic |
— |
| RS2062264317 |
COLQ
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 5, Congenital myasthenic syndrome |
| RS2062288510 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS2062290972 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS2062292476 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS2062303387 |
SCN5A
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2062306727 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS2062306921 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |